Published on 2 Aug 2023 on Zacks via Yahoo Finance
Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates
Pulmonx Corporation (LUNG) came out with a quarterly loss of $0.43 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.
A quarter ago, it was expected that this company would post a loss of $0.43 per share when it actually produced a loss of $0.42, delivering a surprise of 2.33%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.